Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities.
暂无分享,去创建一个
[1] Ronald W. Alfa,et al. Mouse model of Timothy syndrome recapitulates triad of autistic traits , 2011, Proceedings of the National Academy of Sciences.
[2] A. Wilde,et al. UvA-DARE ( Digital Academic Repository ) Variable Na ( v ) 1 . 5 Protein Expression from the Wild-Type Allele Correlates with the Penetrance of Cardiac Conduction Disease in the Scn 5 a ( + /-) Mouse Model , 2010 .
[3] S. Chugh. Early identification of risk factors for sudden cardiac death , 2010, Nature Reviews Cardiology.
[4] J. Nerbonne,et al. Stabilization of Kv4 protein by the accessory K+ channel interacting protein 2 (KChIP2) subunit is required for the generation of native myocardial fast transient outward K+ currents , 2013, The Journal of physiology.
[5] E. Schulze-Bahr,et al. Arrhythmia-associated cardiac Ca2+ cycling proteins and gene mutations , 2012, Wiener Medizinische Wochenschrift.
[6] M. Papadakis,et al. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. , 2013, Journal of the American College of Cardiology.
[7] W. Shen,et al. Atrial fibrillation , 2013, Journal of biomedical research.
[8] J. Bigger,et al. Sudden cardiac death in patients with diabetes , 2004, Current diabetes reports.
[9] Mark E. Anderson,et al. Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.
[10] E. Zaklyazminskaya,et al. Cardiac channelopathies: genetic and molecular mechanisms. , 2013, Gene.
[11] M. Lei,et al. Pathophysiological Mechanisms of Sino-Atrial Dysfunction and Ventricular Conduction Disease Associated with SCN5A Deficiency: Insights from Mouse Models , 2012, Front. Physio..
[12] Mehmet K. Aktas,et al. Congenital Long and Short QT Syndromes , 2012, Cardiology.
[13] J. Nerbonne,et al. Distinct Cellular and Molecular Mechanisms Underlie Functional Remodeling of Repolarizing K+ Currents With Left Ventricular Hypertrophy , 2008, Circulation research.
[14] Can Yuan,et al. Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8). , 2014, Journal of molecular and cellular cardiology.
[15] Elisabetta Cerbai,et al. Role of potassium currents in cardiac arrhythmias. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] Sara Negri,et al. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. , 2006, Circulation research.
[17] X. Wehrens,et al. Animal models of arrhythmogenic cardiomyopathy , 2009, Disease Models & Mechanisms.
[18] D. Christini,et al. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of IK,slow1 and Ito,f , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] Michael D. Schneider,et al. Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43 , 2001, Circulation research.
[20] S. Lehnart. Understanding the physiology of heart failure through cellular and in vivo models‐towards targeting of complex mechanisms , 2013, Experimental physiology.
[21] S. Priori,et al. Inherited calcium channelopathies in the pathophysiology of arrhythmias , 2012, Nature Reviews Cardiology.
[22] Burcu Duygu,et al. Genetics and epigenetics of arrhythmia and heart failure , 2013, Front. Genet..
[23] F. Charpentier,et al. Mouse models of SCN5A-related cardiac arrhythmias. , 2008, Progress in biophysics and molecular biology.
[24] Carlo Napolitano,et al. Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia , 2013, Circulation research.
[25] J. Kalman,et al. Update on the management of atrial fibrillation , 2013, The Medical journal of Australia.
[26] J. Baizer,et al. A Mouse Model of Timothy Syndrome: a Complex Autistic Disorder Resulting from a Point Mutation in Cav1.2. , 2012, North American journal of medicine & science.
[27] G. Breithardt,et al. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. , 2003, Cardiovascular research.
[28] Linuo Zhou,et al. Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review. , 2009, Current diabetes reviews.
[29] D. McEwen,et al. Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. , 2007, Journal of molecular and cellular cardiology.
[30] J. Nerbonne,et al. Enhanced cardiac PI3Kα signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure. , 2012, Cardiovascular research.
[31] K. Willecke,et al. Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels , 2013, Basic Research in Cardiology.
[32] J. Epstein,et al. Notch signaling regulates murine atrioventricular conduction and the formation of accessory pathways. , 2011, The Journal of clinical investigation.
[33] 李永军,et al. Atrial Fibrillation , 1999 .
[34] D. Escande,et al. Cardiac channelopathies: from men to mice , 2004, Annals of medicine.
[35] Jie Zhang,et al. Contactin-2 Expression in the Cardiac Purkinje Fiber Network , 2010, Circulation. Arrhythmia and electrophysiology.
[36] B. London,et al. Cardiac Arrhythmias: From (Transgenic) Mice to Men , 2001, Journal of cardiovascular electrophysiology.
[37] B. Gersh,et al. Sudden cardiac death: epidemiology and risk factors , 2010, Nature Reviews Cardiology.
[38] W. Catterall,et al. Sudden unexpected death in a mouse model of Dravet syndrome. , 2013, The Journal of clinical investigation.
[39] J. Nerbonne. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms? , 2004, Trends in cardiovascular medicine.
[40] M. Faggioni,et al. Calsequestrin 2 and arrhythmias. , 2012, American journal of physiology. Heart and circulatory physiology.
[41] A. Buxton,et al. Left Ventricular Ejection Fraction for Sudden Death Risk Stratification and Guiding Implantable Cardioverter-defibrillators Implantation , 2010, Journal of cardiovascular pharmacology.
[42] J. Ross,et al. A Defect in the Kv Channel-Interacting Protein 2 (KChIP2) Gene Leads to a Complete Loss of I to and Confers Susceptibility to Ventricular Tachycardia , 2001, Cell.
[43] J. Epstein,et al. Myocardial Notch Signaling Reprograms Cardiomyoctes to a Conduction‐Like Phenotype , 2012, Circulation.
[44] Willem Flameng,et al. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome , 2001, Nature Medicine.
[45] J. Nerbonne,et al. Molecular physiology of cardiac repolarization. , 2005, Physiological reviews.
[46] S. Demolombe,et al. Early ion-channel remodeling and arrhythmias precede hypertrophy in a mouse model of complete atrioventricular block. , 2011, Journal of molecular and cellular cardiology.
[47] D. Terentyev,et al. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. , 2007, Cardiovascular research.